Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Mar 23, 2023
- Accession no.
- 0001209191-23-020688
- Filed
- Mar 23, 2023, 6:52 AM ET
- Trade date
- Mar 22, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market purchases total $264.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2023 | Common Stock | PPurchaseAcquired | +700 | $1.31 | +$917 | 199,832,394 | Indirect | |
| Mar 22, 2023 | Common Stock | PPurchaseAcquired | +57,100 | $1.32 | +$75,086.5 | 199,889,494 | Indirect | |
| Mar 22, 2023 | Common Stock | PPurchaseAcquired | +25,200 | $1.32 | +$33,264 | 199,914,694 | Indirect | |
| Mar 22, 2023 | Common Stock | PPurchaseAcquired | +116,648 | $1.33 | +$154,558.6 | 200,031,342 | Indirect | |
| Mar 22, 2023 | Common Stock | PPurchaseAcquired | +352 | $1.33 | +$468.16 | 200,031,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.